Copyright Reports & Markets. All rights reserved.

Global Full Electroporation System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Full Electroporation System Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Eukaryotic Cells
    • 1.3.3 Prokaryotic Cell
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Full Electroporation System Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Life Sciences Research
    • 1.4.3 Biopharmaceuticals & Gene Therapy
    • 1.4.4 Agriculture & Plant Sciences
    • 1.4.5 Others
  • 1.5 Global Full Electroporation System Market Size & Forecast
    • 1.5.1 Global Full Electroporation System Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Full Electroporation System Sales Quantity (2021-2032)
    • 1.5.3 Global Full Electroporation System Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bio-Rad
    • 2.1.1 Bio-Rad Details
    • 2.1.2 Bio-Rad Major Business
    • 2.1.3 Bio-Rad Full Electroporation System Product and Services
    • 2.1.4 Bio-Rad Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bio-Rad Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Full Electroporation System Product and Services
    • 2.2.4 Thermo Fisher Scientific Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 Nepa Gene
    • 2.3.1 Nepa Gene Details
    • 2.3.2 Nepa Gene Major Business
    • 2.3.3 Nepa Gene Full Electroporation System Product and Services
    • 2.3.4 Nepa Gene Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Nepa Gene Recent Developments/Updates
  • 2.4 BTX
    • 2.4.1 BTX Details
    • 2.4.2 BTX Major Business
    • 2.4.3 BTX Full Electroporation System Product and Services
    • 2.4.4 BTX Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BTX Recent Developments/Updates
  • 2.5 Lonza
    • 2.5.1 Lonza Details
    • 2.5.2 Lonza Major Business
    • 2.5.3 Lonza Full Electroporation System Product and Services
    • 2.5.4 Lonza Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lonza Recent Developments/Updates
  • 2.6 BEX
    • 2.6.1 BEX Details
    • 2.6.2 BEX Major Business
    • 2.6.3 BEX Full Electroporation System Product and Services
    • 2.6.4 BEX Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BEX Recent Developments/Updates
  • 2.7 STEMCELL
    • 2.7.1 STEMCELL Details
    • 2.7.2 STEMCELL Major Business
    • 2.7.3 STEMCELL Full Electroporation System Product and Services
    • 2.7.4 STEMCELL Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 STEMCELL Recent Developments/Updates
  • 2.8 Labtron
    • 2.8.1 Labtron Details
    • 2.8.2 Labtron Major Business
    • 2.8.3 Labtron Full Electroporation System Product and Services
    • 2.8.4 Labtron Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Labtron Recent Developments/Updates
  • 2.9 MaxCyte
    • 2.9.1 MaxCyte Details
    • 2.9.2 MaxCyte Major Business
    • 2.9.3 MaxCyte Full Electroporation System Product and Services
    • 2.9.4 MaxCyte Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 MaxCyte Recent Developments/Updates
  • 2.10 Celetrix Biotechnologies
    • 2.10.1 Celetrix Biotechnologies Details
    • 2.10.2 Celetrix Biotechnologies Major Business
    • 2.10.3 Celetrix Biotechnologies Full Electroporation System Product and Services
    • 2.10.4 Celetrix Biotechnologies Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Celetrix Biotechnologies Recent Developments/Updates
  • 2.11 Biontex
    • 2.11.1 Biontex Details
    • 2.11.2 Biontex Major Business
    • 2.11.3 Biontex Full Electroporation System Product and Services
    • 2.11.4 Biontex Full Electroporation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Biontex Recent Developments/Updates

3 Competitive Environment: Full Electroporation System by Manufacturer

  • 3.1 Global Full Electroporation System Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Full Electroporation System Revenue by Manufacturer (2021-2026)
  • 3.3 Global Full Electroporation System Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Full Electroporation System by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Full Electroporation System Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Full Electroporation System Manufacturer Market Share in 2025
  • 3.5 Full Electroporation System Market: Overall Company Footprint Analysis
    • 3.5.1 Full Electroporation System Market: Region Footprint
    • 3.5.2 Full Electroporation System Market: Company Product Type Footprint
    • 3.5.3 Full Electroporation System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Full Electroporation System Market Size by Region
    • 4.1.1 Global Full Electroporation System Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Full Electroporation System Consumption Value by Region (2021-2032)
    • 4.1.3 Global Full Electroporation System Average Price by Region (2021-2032)
  • 4.2 North America Full Electroporation System Consumption Value (2021-2032)
  • 4.3 Europe Full Electroporation System Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Full Electroporation System Consumption Value (2021-2032)
  • 4.5 South America Full Electroporation System Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Full Electroporation System Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Full Electroporation System Sales Quantity by Type (2021-2032)
  • 5.2 Global Full Electroporation System Consumption Value by Type (2021-2032)
  • 5.3 Global Full Electroporation System Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Full Electroporation System Sales Quantity by Application (2021-2032)
  • 6.2 Global Full Electroporation System Consumption Value by Application (2021-2032)
  • 6.3 Global Full Electroporation System Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Full Electroporation System Sales Quantity by Type (2021-2032)
  • 7.2 North America Full Electroporation System Sales Quantity by Application (2021-2032)
  • 7.3 North America Full Electroporation System Market Size by Country
    • 7.3.1 North America Full Electroporation System Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Full Electroporation System Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Full Electroporation System Sales Quantity by Type (2021-2032)
  • 8.2 Europe Full Electroporation System Sales Quantity by Application (2021-2032)
  • 8.3 Europe Full Electroporation System Market Size by Country
    • 8.3.1 Europe Full Electroporation System Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Full Electroporation System Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Full Electroporation System Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Full Electroporation System Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Full Electroporation System Market Size by Region
    • 9.3.1 Asia-Pacific Full Electroporation System Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Full Electroporation System Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Full Electroporation System Sales Quantity by Type (2021-2032)
  • 10.2 South America Full Electroporation System Sales Quantity by Application (2021-2032)
  • 10.3 South America Full Electroporation System Market Size by Country
    • 10.3.1 South America Full Electroporation System Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Full Electroporation System Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Full Electroporation System Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Full Electroporation System Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Full Electroporation System Market Size by Country
    • 11.3.1 Middle East & Africa Full Electroporation System Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Full Electroporation System Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Full Electroporation System Market Drivers
  • 12.2 Full Electroporation System Market Restraints
  • 12.3 Full Electroporation System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Full Electroporation System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Full Electroporation System
  • 13.3 Full Electroporation System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Full Electroporation System Typical Distributors
  • 14.3 Full Electroporation System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Full Electroporation System market size was valued at US$ 215 million in 2025 and is forecast to a readjusted size of US$ 405 million by 2032 with a CAGR of 9.6% during review period.
    A Full Electroporation System is a physical transfection device that applies controlled electrical pulses to temporarily create micropores in the cell membrane, allowing exogenous substances such as nucleic acids to enter the cell. This system enables efficient gene delivery across a wide range of cell types, including bacterial, yeast, plant, and mammalian cells. It is widely used in applications such as gene transfection, gene editing, vaccine development, and cell therapy, serving as a critical tool in both research and industrial-scale cell engineering.
    Full Electroporation Systems are essential physical transfection platforms widely used across life sciences research and biopharmaceutical industries. In academic settings, companies like Bio-Rad, BTX, and Nepa Gene offer versatile benchtop systems with broad cell-type compatibility, emphasizing reproducibility and ease of use. In contrast, industrial players such as MaxCyte, Lonza, and Celetrix Biotechnologies provide GMP-compliant, high-throughput systems tailored for applications like CAR-T manufacturing and mRNA delivery. Integrated solutions from Thermo Fisher Scientific and STEMCELL Technologies combine electroporation instruments with reagents and protocols to enhance workflow consistency. The market exhibits a dual structure—academic-driven adoption and industrial-scale deployment—where leading global firms maintain a clear competitive edge, with differentiation increasingly based on process scalability and regulatory readiness.
    This report is a detailed and comprehensive analysis for global Full Electroporation System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Full Electroporation System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Full Electroporation System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Full Electroporation System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Full Electroporation System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Full Electroporation System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Full Electroporation System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad, Thermo Fisher Scientific, Nepa Gene, BTX, Lonza, BEX, STEMCELL, Labtron, MaxCyte, Celetrix Biotechnologies, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Full Electroporation System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Eukaryotic Cells
    Prokaryotic Cell
    Others
    Market segment by Application
    Life Sciences Research
    Biopharmaceuticals & Gene Therapy
    Agriculture & Plant Sciences
    Others
    Major players covered
    Bio-Rad
    Thermo Fisher Scientific
    Nepa Gene
    BTX
    Lonza
    BEX
    STEMCELL
    Labtron
    MaxCyte
    Celetrix Biotechnologies
    Biontex
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Full Electroporation System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Full Electroporation System, with price, sales quantity, revenue, and global market share of Full Electroporation System from 2021 to 2026.
    Chapter 3, the Full Electroporation System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Full Electroporation System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Full Electroporation System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Full Electroporation System.
    Chapter 14 and 15, to describe Full Electroporation System sales channel, distributors, customers, research findings and conclusion.

    Buy now